“…IO,16,17 Over the years, epidemiologic studies have correlated Thorotrast exposure to a greatly increased incidence of liver cancer, hepatoma, leukemia, and liver cirrhosis.Ui'f Andersson et a}11 noted a 50% excess mortality in patients exposed to Thorotrast, mainly due to liver disease. 3,6,15,16 France prohibited the use ofThorotrast in 1935,10,15 afterresearchers there discovered that the contrast agent induced sarcomas in laboratory animals.…”